N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels

AIMS: Elevated apolipoprotein C-III (apoC-III) levels are associated with hypertriglyceridaemia and coronary heart disease. AKCEA-APOCIII-L(Rx) is an N-acetyl galactosamine-conjugated antisense oligonucleotide targeted to the liver that selectively inhibits apoC-III protein synthesis. METHODS AND RE...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Heart J
Auteurs principaux: Alexander, Veronica J, Xia, Shuting, Hurh, Eunju, Hughes, Steven G, O’Dea, Louis, Geary, Richard S, Witztum, Joseph L, Tsimikas, Sotirios
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Fast Track Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736334/
https://ncbi.nlm.nih.gov/pubmed/31329855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehz209
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires